blue_space

ABOUT

the Association for Behavioral Health & Wellness

The Association for Behavioral Health and Wellness (ABHW) is the national voice for payers that manage behavioral health insurance benefits. ABHW member companies provide coverage to over 175 million people in both the public and private sectors to treat mental health, substance use disorders, and other behaviors that impact human health and wellness.

Founded in 1994, ABHW is a respected leader in the behavioral health and medical arena. Poised to effect positive policy change, ABHW provides thought leadership and advocates for regulations and policies that help provide high quality health care to promote healthy living and improved quality of life.

 

Our Guiding

Principles



 

ABHW

Board of Directors



Leadership Board of Directors
Michael Golinkoff, Ph.D, MBA; Chairman of the Board
President
PerformCare
Marianne Burdison, LCSW
Senior Director, Strategic Alliances & Development
Centene Corporation
Sherry Dubester, MD, MS; Treasurer of the Board
Vice President, Behavioral Health and Clinical Programs
Anthem
Jay Curley
Executive Vice President, Corporate Affairs
Chief of Staff to the CEO
Beacon Health Options
Doug Nemecek, MD, MBA; Chairman Elect
Chief Medical Officer - Behavioral Health
Cigna
Adam R. Easterday
Deputy General Counsel
Optum



Mark Friedlander, MD, MBA
Chief Medical Officer
Aetna Behavioral Health



John Quick, Ph.D
Consultant
New Directions Behavioral Health



Lawrence M. Weinstein, MD, ABHM
Chief Medical Officer
Humana Behavioral Health



Staff



Pamela Greenberg, MPP
President and CEO

Pamela Greenberg joined ABHW as the Executive Director in 1998. Ms. Greenberg serves on the Editorial Board of the Bloomberg BNA Health Insurance Report and she is a liaison to the National Committee for Quality Assurance Standards Committee. In 2015, Ms. Greenberg joined the Advisory Board of Landmark Health a company that provides home-based medical care to individuals with multiple chronic conditions and in 2017 she joined InnovaTel Telepsychiatry’s Strategic Advisory Board.

Ms. Greenberg was the Chair of the Coalition for Fairness in Mental Illness Coverage, one of the leading Coalitions that helped develop, advocate for, and get the Wellstone-Domenici Mental Health Parity and Addiction Equity Act of 2008 signed in to law. Additionally, Pamela served as President of ACMHA: The College for Behavioral Health Leadership. Prior to joining ABHW Pamela was the Deputy Director of Federal Affairs for America’s Health Insurance Plans (AHIP) and previously served as a Legislative Assistant at Capitol Associates in Washington, D.C.

Pamela has a B.A. from Mount Holyoke College and a Masters in Public Policy from Georgetown University.



Tiffany Huth
Director, Communications and Public Affairs

Tiffany joined ABHW in 2017 as the Director of Communications and Public Affairs. In this newly created role, Ms. Huth is responsible for oversight and management of communications, public affairs, marketing, and branding activity for the Association. Ms. Huth also serves as the key strategic communications advisor to ABHW's President and CEO, Pamela Greenberg, and to the ABHW Board of Directors.

Prior to joining ABHW, Tiffany was the Director of Public Affairs at the Personalized Medicine Coalition, an organization dedicated to the understanding and adoption of precision medicine concepts and services. She previously served in a variety of senior communications and public affairs positions at the Association for Psychological Sciences, the American Chemistry Council, and the National Center for Genome Resources, as well as consulting for rare disease and healthcare companies. Ms. Huth received a B.S. from Southern Methodist University and her Masters from Texas Women's University. She is currently an MPH candidate at the Milken Institute School of Public Health at George Washington University.



Rebecca Murow Klein
Director, Government Affairs

Rebecca Murow Klein joined the Association for Behavioral Health and Wellness (ABHW) in 2013. As the Director of Government Affairs, she leads the organization’s efforts to inform policy makers on issues related to behavioral health, including telementalhealth, health care integration, and substance use disorder privacy regulations. Rebecca chairs the Partnership to Amend 42 CFR Part 2, a coalition that is advocating to align 42 CFR Part 2 with HIPAA for the purposes of health care treatment, payment, and operations.

Prior to joining ABHW, Rebecca served as Legislative Assistant for Health and Education Policy in the office of Senator Ben Nelson (D-NE). She holds a B.A. from the University of Michigan and is currently a candidate for Master of Business Administration and Master of Arts in Government at the Johns Hopkins University.




 

Members

Aetna Behavioral Health
Anthem
Beacon Health Options
Centene Corporation
Cigna
Humana Behavioral Health
New Directions Behavioral Health
Optum
PerformCare

 

Corporate

Partners

Alkermes
Braeburn Pharmaceuticals
Genomind
Indivior
Johnson & Johnson Health Care Systems, Inc.
Neurocrine Biosciences
ODH, Inc.
Pear Therapeutics

ABHW

Perspectives

CONSUMER TIPS: NAVIGATING YOUR PRIOR AUTHORIZATION.

Behavioral health is complex. Untreated behavioral health conditions, including both mental health and substance use disorders, have a significant impact on individuals, families, friends, and employers. Individuals with mental health conditions and/or substance use disorders need access to evidence-based services - the care that, based on scientific research, has been shown to...

[More]

View all entries

NEW

ABHW

Publications

October 26, 2017 ABHW Statement On The Trump Administration's Opioid Announcement.

October 20, 2017 Statement of Pamela Greenberg, MPP, President and CEO, Association for Behavioral Health and Wellness, Before the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

October 18, 2017 Media Alert – Congressional Briefing, Using Health IT to Combat the Opioid Crisis.

October 16, 2017 ABHW Letter of Support on the Partnership to Amend 42 CFR Part 2.

October 13, 2017 Association for Behavioral Health and Wellness CEO to Speak at White House Opioid Crisis Commission Meeting.

October 12, 2017 ABHW CEO to Chair Payer Behavioral Health Conference in Washington, DC.

September 26, 2017 Health Care Coalition Lauds Manchin and Capito’s “Legacy Act”.

September 26, 2017 ABHW Applauds Senators Manchin and Capito’s “Legacy Act” in Honor of Jessie Grubb.

September 22, 2017 Graham-Cassidy Health Care Bill is Unacceptable.

September 12, 2017 FAQ About Mental Health and Substance Use Disorder Parity Implementation and the 21st Century Cures Act Part 38.

September 8, 2017 Media Alert – ABHW is pleased to present a briefing on the role of U.S.behavioral health plans in addressing the opioid epidemic.

August 10, 2017 Insurer Industry Group Commends President’s Declaration of National Emergency Over Opioid Epidemic.

August 1, 2017 ABHW Supports Steps Taken by White House Commission on Opioids.

July 28, 2017 42 CFR Part 2 Coalition Applauds Bipartisan Bill to Strengthen Addiction Treatment.

July 28, 2017 ABHW Applauds Congressman Murphy’s Bipartisan Bill to Strengthen Addiction Treatment.

July 27, 2017 ABHW Comments to the Opioid Commission.

July 27, 2017 ABHW Written Comments for HHS Listening Session on Strategies for Improving Parity for Mental Health and Substance Use Disorder Coverage.

July 12, 2017 ABHW President and CEO to Speak at 2017 Government Health Care Congress.

June 26, 2017 ABHW Letter in Support of the Nomination of Elinore F. McCance-Katz, MD, PhD, for Assistant Secretary for Mental Health and Substance Use.

May 23, 2017 ABHW Letter to Chairman Hatch on Health Care Reform Process in the Senate.

May 4, 2017 Press Release: ABHW Issues Statement in Wake of House Passage of AHCA.

May 2, 2017 ABHW Letter to House Leadership on AHCA and MacArthur Amendment.

April 26, 2017 Press Release: ABHW to Chair Inaugural Payer-Provider Behavioral Health Management Summit.

April 25, 2017 Press Release: ABHW Recommends Improvements to Medicare Advantage Program.

March 30, 2017 Press Release: ABHW Welcomes White House Commission on Opioids.

March 23, 2017 ABHW Letter to House Leadership Over AHCA Concerns.

March 22, 2017 ABHW Letter to House Leadership on ACHA.

March 17, 2017 ABHW Press Release on Confirmation of New HHS Secretary Price and CMS Administrator Verma.

March 10, 2017 ABHW Comments to Rep Murphy.

March 8, 2017 ABHW Comment Letter on Market Stabilization Prop Rule.

February 17, 2017 ABHW Press Release on SNPRM Part 2 Comment Letter.

February 17, 2017 ABHW SNPRM Comment Letter to SAMHSA on Confidentiality.

February 1, 2017 ABHW Summary of 42 CFR Part 2 Final Rule and SNPRM.

Any

Questions?

Contact us anytime